Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Lipoprotein Lipase Antikörper

LPL Reaktivität: Human, Rind (Kuh) WB, ELISA Monoclonal unconjugated
Produktnummer ABIN966491
  • Target Alle Lipoprotein Lipase (LPL) Antikörper anzeigen
    Lipoprotein Lipase (LPL)
    Reaktivität
    • 72
    • 28
    • 22
    • 15
    • 5
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Human, Rind (Kuh)
    Wirt
    Bitte anfragen
    Klonalität
    • 55
    • 24
    Monoklonal
    Konjugat
    • 35
    • 7
    • 6
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser Lipoprotein Lipase Antikörper ist unkonjugiert
    Applikation
    • 62
    • 32
    • 32
    • 23
    • 15
    • 14
    • 14
    • 8
    • 7
    • 5
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA
    Spezifität
    Human LPL whole protein. Recognizes specifically LPL from human and bovine.
    Isotyp
    IgG1
    Top Product
    Discover our top product LPL Primärantikörper
  • Applikationshinweise
    Western blot (1:1000) and ELISA (1:2000~5000) in lipid metabolic research.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1mg/ml
    Buffer
    PBS, pH 7.4
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
  • Target
    Lipoprotein Lipase (LPL)
    Andere Bezeichnung
    LPL (LPL Produkte)
    Synonyme
    HDLCQ11 antikoerper, LIPD antikoerper, fb62e04 antikoerper, fc49b03 antikoerper, wu:fb62e04 antikoerper, wu:fc49b03 antikoerper, LPL antikoerper, lipd antikoerper, hdlcq11 antikoerper, lpl antikoerper, LOC100223817 antikoerper, lipoprotein lipase antikoerper, LPL antikoerper, Lpl antikoerper, lpl antikoerper
    Hintergrund
    Lipoprotein lipase (LPL) is the central enzyme in plasma triglyceride hydrolysis and is secreted by macrophages in the subendothelial space. Evidence has been provided that LPL produced by macrophages in the vessel wall exerts proatherogenic effects. The atherogenic effects of LPL have been mainly attributed to its ability to favor lipid accumulation within macrophages present in the atherosclerotic lesion. Recently, it has also been shown that LPL promote the development of atherosclerosis through facilitation of monocyte adhesion to endothelial cells, stimulation of tumor necrosis factor alpha (TNF ) secretion and induction of vascular smooth muscle cell proliferation.
    Gen-ID
    4023
    Pathways
    Lipid Metabolism
Sie sind hier:
Kundenservice